Biotie acquiring neurology company Synosia in a stock deal valued at €96.9 million ($131.9 million)

Synosia Therapeutics AG

Switzerland / Private Biopharma

Seller

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Biotie Therapies Corp.

Finland / Small-Cap Biopharma (<$1 billion)

$140.7m on 01/14/2011 [market cap]

Buyer

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Completed

Sample

01/01/2009

announced

01/01/2009

completed